MedTrace Logo

Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry

NCT03724435 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2024-03-18

No results posted yet for this study

Summary

This pancreatic cancer registry aims to collect information on people around the world who select focused ultrasound (FUS) as part of their treatment for pancreatic cancer to learn about the performance of the focused ultrasound technology and health outcomes; the impact of focused ultrasound on your overall health; and provide an understanding of the current care for pancreatic cancer.

Conditions

Sponsors & Collaborators

  • Navitas Clinical Research, Inc

    collaborator UNKNOWN

  • Focused Ultrasound Foundation

    lead OTHER

Principal Investigators

  • Joo Ha Hwang, MD, PhD · Stanford University

  • Joan Vidal-Jove, MD, PhD · Hospital Universitario Mútua Terrassa

  • Tim Meakem, MD · Focused Ultrasound Foundation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-06
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Bulgaria
  • South Korea
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03724435 on ClinicalTrials.gov